Evidence map›Paper›PMID 12843241›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2003

Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.

Kevin C Kanning, Mark Hudson, Paul S Amieux, Jesse C Wiley, Mark Bothwell, Leslayann C Schecterson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
7.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 249 citations in OpenAlex.

  1. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.Biochimica et biophysica acta. Reviews on cancer · 2026
    Review
  2. Resistance of E2F4DN to p38Scientific reports · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Mage-D1 binding to activated p75NTR positively regulates mineralization of rat ectomesenchymal stem cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Unraveling the complexity of γ-secretase.Seminars in cell & developmental biology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kevin C KanningDepartment of Physiology and Biophysics, University of Washington, Seattle, Washington 98195, USA.
Mark Hudson
Paul S Amieux
Jesse C Wiley
Mark Bothwell
Leslayann C Schecterson
University of Washington · US

Funding

NEUROBIOLOGYT32GM007108 · NIGMS · UNIVERSITY OF WASHINGTON · PI BINDER, MARC D · 1985 to 2014
$6.1M
NEUROTROPHIN RECEPTOR INTERACTIONSR01NS033200 · NINDS · UNIVERSITY OF WASHINGTON · PI BOTHWELL, MARK ALLEN · 1995 to 2004
$1.6M
NIGMS NIH HHS 5 T32 GM07108NIGMS NIH HHS T32 GM007108NINDS NIH HHS R01 NS033200NINDS NIH HHS R01NS33200
6 · The paper itself

Abstract

The 75 kDa neurotrophin receptor (p75NTR) and two neurotrophin receptor homologs (NRH1, NRH2) constitute a subfamily of the nerve growth factor/tumor necrosis factor receptor superfamily. NRH1 coexists with p75NTR in fish, amphibians, and birds but is absent in mammals, whereas NRH2 exists only in mammals. Unlike p75NTR and NRH1, NRH2 lacks a canonical extracellular ligand binding domain. The similarity of NRH2 to the product of metalloproteinase cleavage of p75NTR prompted us to examine the cleavage of p75NTR in greater detail. p75NTR, NRH1, and NRH2 undergo multiple proteolytic cleavages that ultimately release cytoplasmic fragments. For p75NTR, cleavage in the extracellular domain by a PMA-inducible membrane metalloproteinase is followed by cleavage within or near the transmembrane domain, releasing the intracellular domain into the cytoplasm. This processing resembles the alpha- and gamma-secretase-mediated processing of beta-amyloid precursor protein and the similar processing of Notch. Although neurotrophins did not regulate p75NTR processing, the alpha- and gamma-secretase-mediated cleavage of p75 is modulated by receptor tyrosine kinases (Trks) TrkA and TrkB but not TrkC. Surprisingly, although NRH1 and NRH2 also undergo proteolytic cytoplasmic release of intracellular domains, a different protease mediates the cleavage. Furthermore, whereas the p75NTR soluble intracellular domain accumulates only in the presence of proteasome inhibitors, the equivalent fragment of NRH2 is stable and localizes in the nucleus. Because soluble intracellular domains of p75NTR and NRH2 were found to activate NF-kappaB in concert with TNF receptor associated factor 6 (TRAF6), we propose that cleavage of these proteins may serve conserved cytoplasmic and nuclear signaling functions through distinct proteases.

Indexed as

Amyloid Precursor Protein SecretasesAnimalsApoptosis Regulatory ProteinsAspartic Acid EndopeptidasesCarrier ProteinsCell LineEcdysteroneEndopeptidasesEnzyme ActivatorsEnzyme InhibitorsHumansMembrane ProteinsMolecular Sequence DataNF-kappa BPeptide FragmentsProtein Processing, Post-TranslationalAmyloid Precursor Protein SecretasesApoptosis Regulatory ProteinsAspartic Acid EndopeptidasesBACE1 protein, humanBace1 protein, mouseCarrier ProteinsEcdysteroneEndopeptidasesEnzyme ActivatorsEnzyme InhibitorsMembrane ProteinsNF-kappa BNradd protein, ratNRH1 protein, XenopusNRH2 protein, mousePeptide Fragmentsponasterone AProteinsReceptor, Nerve Growth FactorReceptors, Nerve Growth FactorTNF Receptor-Associated Factor 6

Identifiers

PMID12843241
PMCPMC6741218
OpenAlexW1605328799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.